Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo
Beyond glycemic control, large outcome studies have confirmed that certain GLP-1 agonists significantly improve cardiovascular outcomes (reducing heart attacks, stroke, or cardiovascular death) in high-risk diabetic patients ( [8] ) ( [9] )
Studies consistently show altered MGBA composition in AD patients, suggesting a possible role in disease onset and progression, as shown in Table 1
FDA Disclaimer: This product is not intended to diagnose, treat, cure, or prevent any disease
It has been investigated for potential effects on skin pigmentation, based on proposed mechanisms including influence on melanin synthesis pathways